Engineered human pluripotent stem cell-derived natural killer cells: the next frontier for cancer immunotherapy

Adoptive immunotherapy using immune effector cells has revolutionized cancer treatments with approval of two autologous chimeric antigen receptor (CAR) T cell therapies by the US FDA. Clinical trials using natural killer (NK) cell-based adoptive immunotherapy have been shown to be safe and effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Huang, Kaufman, Dan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974906/
https://www.ncbi.nlm.nih.gov/pubmed/35402797
http://dx.doi.org/10.1097/BS9.0000000000000023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974906/
https://www.ncbi.nlm.nih.gov/pubmed/35402797
http://dx.doi.org/10.1097/BS9.0000000000000023

Ejemplares similares